• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

G蛋白偶联雌激素受体1(GPER1)的过表达对子宫颈癌细胞侵袭性的影响取决于组织学类型。

G-Protein-coupled Estrogen Receptor 1 (GPER1) Overexpression Affects Aggressiveness of Cervical Carcinoma Cells Depending on Histological Entity.

作者信息

Hambach Lena, Gallwas Julia, Gründker Carsten

机构信息

Department of Gynecology and Obstetrics, University Medical Center Göttingen, Göttingen, Germany.

Department of Gynecology and Obstetrics, University Medical Center Göttingen, Göttingen, Germany

出版信息

Cancer Genomics Proteomics. 2025 May-Jun;22(3):397-414. doi: 10.21873/cgp.20509.

DOI:10.21873/cgp.20509
PMID:40280720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12041873/
Abstract

BACKGROUND/AIM: Cervical cancer (CC) is the fourth most common cancer in women worldwide. There are two main histological subtypes of CC: the more common cervical squamous cell carcinoma (CSCC) and the rarer cervical adenocarcinoma (CAC), which has a poorer prognosis. Unlike estrogen receptor (ER) α and ERβ, G-protein-coupled estrogen receptor 1 (GPER1) is recognized as a rapid mediator of cellular estrogenic action and tends to have tumor suppressive properties in CC. Since a clinical study showed that an elevated GPER1 expression is associated with a worse prognosis, we investigated the effects of stable GPER1 overexpression (GPER1-OE) on SiHa CSCC and HeLa CAC cells.

MATERIALS AND METHODS

SiHa CSCC and HeLa CAC cells with stable GPER1-OE were generated. GPER1-OE was tested by RT-qPCR, western blot and fluorescence-activated cell analysis (FACS). The effects of GPER1-OE on proliferation, migration, invasion, apoptosis and stem cell properties (colony and sphere formation) were then examined.

RESULTS

Successful GPER1-OE in SiHa CSCC and HeLa CAC cells was confirmed. The cell characterization experiments showed that SiHa CSCC cells with stable GPER1-OE had faster proliferation and migration, and increased stem cell properties with larger and more numerous colonies and larger tumor spheres. In HeLa CAC cells, on the other hand, GPER1-OE resulted in slower cell proliferation, migration and invasion, reduced colony formation and tumor sphere formation. An increased rate of apoptosis was also observed.

CONCLUSION

GPER1-OE resulted in a more aggressive tumor behavior of SiHa CSCC cells and a less aggressive tumor behavior of HeLa CAC cells, due to a different effect of GPER1 overexpression depending on the respective histological subtypes of CC. This underlines the need for personalized medicine and a precise differentiation of subtypes in CC-related research.

摘要

背景/目的:宫颈癌(CC)是全球女性中第四大常见癌症。CC主要有两种组织学亚型:较常见的宫颈鳞状细胞癌(CSCC)和较罕见的宫颈腺癌(CAC),后者预后较差。与雌激素受体(ER)α和ERβ不同,G蛋白偶联雌激素受体1(GPER1)被认为是细胞雌激素作用的快速介质,在CC中往往具有肿瘤抑制特性。由于一项临床研究表明GPER1表达升高与预后较差有关,我们研究了稳定过表达GPER1(GPER1-OE)对SiHa CSCC细胞和HeLa CAC细胞的影响。

材料与方法

构建了稳定过表达GPER1的SiHa CSCC细胞和HeLa CAC细胞。通过逆转录定量聚合酶链反应(RT-qPCR)、蛋白质免疫印迹法和荧光激活细胞分析(FACS)检测GPER1-OE。然后检测GPER1-OE对细胞增殖、迁移、侵袭、凋亡和干细胞特性(集落和球体形成)的影响。

结果

证实了在SiHa CSCC细胞和HeLa CAC细胞中成功实现了GPER1-OE。细胞特性实验表明,稳定过表达GPER1的SiHa CSCC细胞增殖和迁移更快,干细胞特性增强,形成更大、更多的集落和更大的肿瘤球体。另一方面,在HeLa CAC细胞中,GPER1-OE导致细胞增殖、迁移和侵袭减慢,集落形成和肿瘤球体形成减少。还观察到凋亡率增加。

结论

由于GPER1过表达对CC各自组织学亚型的影响不同,GPER1-OE导致SiHa CSCC细胞的肿瘤行为更具侵袭性,而HeLa CAC细胞的肿瘤行为侵袭性较小。这凸显了在CC相关研究中个性化医疗和精确区分亚型的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/1020aeb1559b/cgp-22-410-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/a4a4e256bb1f/cgp-22-400-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/d578c4cce925/cgp-22-403-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/be7028244969/cgp-22-404-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/26d10d338f57/cgp-22-405-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/288a44c17c62/cgp-22-405-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/ea096c88ebe9/cgp-22-406-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/77eb886790b7/cgp-22-407-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/ee5822c16e7d/cgp-22-408-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/461f325391b7/cgp-22-409-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/1020aeb1559b/cgp-22-410-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/a4a4e256bb1f/cgp-22-400-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/d578c4cce925/cgp-22-403-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/be7028244969/cgp-22-404-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/26d10d338f57/cgp-22-405-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/288a44c17c62/cgp-22-405-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/ea096c88ebe9/cgp-22-406-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/77eb886790b7/cgp-22-407-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/ee5822c16e7d/cgp-22-408-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/461f325391b7/cgp-22-409-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9033/12041873/1020aeb1559b/cgp-22-410-g0001.jpg

相似文献

1
G-Protein-coupled Estrogen Receptor 1 (GPER1) Overexpression Affects Aggressiveness of Cervical Carcinoma Cells Depending on Histological Entity.G蛋白偶联雌激素受体1(GPER1)的过表达对子宫颈癌细胞侵袭性的影响取决于组织学类型。
Cancer Genomics Proteomics. 2025 May-Jun;22(3):397-414. doi: 10.21873/cgp.20509.
2
Expression of "Hallmarks of Cancer" Genes in Cervical Carcinoma Is Differentially Affected by GPER1 Overexpression Depending on Histologic Entity.根据组织学类型,宫颈癌中“癌症特征”基因的表达受GPER1过表达的影响存在差异。
Cancer Genomics Proteomics. 2025 May-Jun;22(3):415-433. doi: 10.21873/cgp.20510.
3
G Protein-coupled Estrogen Receptor 1 (GPER1) Regulates Expression of /PAI-1 and Inhibits Tumorigenic Potential of Cervical Squamous Cell Carcinoma Cells .G蛋白偶联雌激素受体1(GPER1)调节纤溶酶原激活物抑制因子-1(PAI-1)的表达并抑制宫颈鳞状细胞癌细胞的致瘤潜能。
Cancer Genomics Proteomics. 2025 Jan-Feb;22(1):13-23. doi: 10.21873/cgp.20482.
4
Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Reduces Aggressiveness of Cervical Carcinoma Cells.替普拉西丁对纤溶酶原激活物抑制剂-1(PAI-1)的抑制作用降低了宫颈癌细胞的侵袭性。
Anticancer Res. 2025 May;45(5):1793-1805. doi: 10.21873/anticanres.17559.
5
Knockdown of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances Tumor-supportive Properties in Cervical Carcinoma Cells.敲低 G 蛋白偶联雌激素受体 1(GPER1)增强宫颈癌细胞的肿瘤支持性。
Cancer Genomics Proteomics. 2023 May-Jun;20(3):281-297. doi: 10.21873/cgp.20381.
6
Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression.雌激素/GPR30 信号通过调节 Claudin-1 的表达促进 ER 阴性宫颈腺癌的恶性潜能。
Neoplasia. 2018 Oct;20(10):1083-1093. doi: 10.1016/j.neo.2018.08.010. Epub 2018 Sep 15.
7
[Expression and clinical significance of Dyrk1b in the specimens and cells of cervical lesions].Dyrk1b在宫颈病变标本及细胞中的表达及临床意义
Zhonghua Fu Chan Ke Za Zhi. 2016 Jan;51(1):40-5. doi: 10.3760/cma.j.issn.0529-567X.2016.01.010.
8
Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells.G 蛋白偶联雌激素受体 1(GPER1)的激活可降低外阴癌的进展。
Int J Mol Sci. 2023 Sep 5;24(18):13705. doi: 10.3390/ijms241813705.
9
[Clinical significance of σ1 receptor over-expression in cervical cancer and the effect of its synthetic ligands on the growth of cervical cancer cells].σ1受体在宫颈癌中的过表达及其合成配体对宫颈癌细胞生长的影响的临床意义
Zhonghua Fu Chan Ke Za Zhi. 2017 Jul 25;52(7):473-482. doi: 10.3760/cma.j.issn.0529-567X.2017.07.008.
10
FOXL2 suppresses proliferation, invasion and promotes apoptosis of cervical cancer cells.FOXL2抑制宫颈癌细胞的增殖、侵袭并促进其凋亡。
Int J Clin Exp Pathol. 2014 Mar 15;7(4):1534-43. eCollection 2014.

引用本文的文献

1
Expression of "Hallmarks of Cancer" Genes in Cervical Carcinoma Is Differentially Affected by GPER1 Overexpression Depending on Histologic Entity.根据组织学类型,宫颈癌中“癌症特征”基因的表达受GPER1过表达的影响存在差异。
Cancer Genomics Proteomics. 2025 May-Jun;22(3):415-433. doi: 10.21873/cgp.20510.

本文引用的文献

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
Long-read sequencing reveals the structural complexity of genomic integration of HPV DNA in cervical cancer cell lines.长读测序揭示了 HPV DNA 在宫颈癌细胞系中基因组整合的结构复杂性。
BMC Genomics. 2024 Feb 20;25(1):198. doi: 10.1186/s12864-024-10101-y.
3
HIF-1α increases the osteogenic capacity of ADSCs by coupling angiogenesis and osteogenesis via the HIF-1α/VEGF/AKT/mTOR signaling pathway.
低氧诱导因子-1α 通过 HIF-1α/VEGF/AKT/mTOR 信号通路耦联血管生成和成骨作用来增加脂肪间充质干细胞的成骨能力。
J Nanobiotechnology. 2023 Aug 7;21(1):257. doi: 10.1186/s12951-023-02020-z.
4
Carcinogenesis and management of human papillomavirus-associated cervical cancer.人乳头瘤病毒相关宫颈癌的致癌作用与管理。
Int J Clin Oncol. 2023 Aug;28(8):965-974. doi: 10.1007/s10147-023-02337-7. Epub 2023 Jun 9.
5
The G protein-coupled oestrogen receptor GPER in health and disease: an update.G 蛋白偶联雌激素受体 GPER 在健康和疾病中的作用:最新进展。
Nat Rev Endocrinol. 2023 Jul;19(7):407-424. doi: 10.1038/s41574-023-00822-7. Epub 2023 May 16.
6
Knockdown of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances Tumor-supportive Properties in Cervical Carcinoma Cells.敲低 G 蛋白偶联雌激素受体 1(GPER1)增强宫颈癌细胞的肿瘤支持性。
Cancer Genomics Proteomics. 2023 May-Jun;20(3):281-297. doi: 10.21873/cgp.20381.
7
Single-Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus-Associated (HPVA) and Non-HPVA Adenocarcinoma.单细胞景观突出了宫颈鳞癌、人乳头瘤病毒相关(HPVA)和非 HPVA 腺癌的异质微环境、新型免疫反应模式、潜在的生物标志物和独特的治疗策略。
Adv Sci (Weinh). 2023 Apr;10(10):e2204951. doi: 10.1002/advs.202204951. Epub 2023 Feb 1.
8
Suppression of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances the Anti-invasive Efficacy of Selective ERβ Agonists.抑制 G 蛋白偶联雌激素受体 1(GPER1)增强选择性雌激素受体β激动剂的抗侵袭作用。
Anticancer Res. 2022 Nov;42(11):5187-5194. doi: 10.21873/anticanres.16025.
9
The Interplay of GPER1 with 17β-Aminoestrogens in the Regulation of the Proliferation of Cervical and Breast Cancer Cells: A Pharmacological Approach.GPER1 与 17β-氨基雌激素在调控宫颈癌细胞和乳腺癌细胞增殖中的相互作用:一种药理学方法。
Int J Environ Res Public Health. 2022 Sep 28;19(19):12361. doi: 10.3390/ijerph191912361.
10
EGFR signaling pathway as therapeutic target in human cancers.表皮生长因子受体信号通路作为人类癌症的治疗靶点。
Semin Cancer Biol. 2022 Oct;85:253-275. doi: 10.1016/j.semcancer.2022.04.002. Epub 2022 Apr 12.